@文章{info:doi/10.2196/14285，作者=“Booth, Alison和Bell, Timothy和Halhol, Sonia和Pan, Shiyu和Welch, Verna和Merinopoulou, Evie和Lambrelli, Dimitra和Cox, Andrew”，标题=“使用社交媒体揭示不适合强化化疗的急性髓系白血病或骨髓增生异常综合征患者的治疗经验和决定:以患者为中心的定性数据分析”，期刊=“J Med Internet Res”，年=“2019”，月=“11”，日=“22”，量=“21”，数=“11”，页数=“e14285”，关键词=“社交媒体;与健康有关的生活质量;成规;白血病;骨髓;急性的;骨髓增生异常综合征;自然语言处理;病人的偏好; qualitative research", abstract="Background: Until recently, treatment options were limited for patients with acute myeloid leukemia and myelodysplastic syndrome (AML and MDS) who are ineligible for intensive chemotherapy. Owing to the condition's rapid progression, it is difficult to identify what is most important to patients when making treatment decisions. Patients' needs can be better addressed by gaining a deeper understanding of their perspectives, which is valuable in the decision-making process. The Food and Drug Administration recently encouraged the use of social media as a tool to gain insight on patients' perspectives regarding symptoms experienced and the impacts of their disease. Objective: This study aimed to use disease-specific social media posts by patients with AML or MDS who are ineligible for intensive chemotherapy and their caregivers to capture factors they feel are most important, and to provide current evidence to inform and characterize these perspectives. Methods: Posts by patients with AML or MDS and their caregivers were extracted from publicly available discussions on 3 large AML- or MDS--specific sites. These posts were manually reviewed to only include patients who are ineligible for intensive chemotherapy. A total of 1443 posts from 220 AML patients/caregivers and 2733 posts from 127 MDS patients/caregivers met the study inclusion criteria. A qualitative data analysis (QDA) of a sample of 85 patients'/caregivers' posts was conducted to identify themes, and a targeted QDA of posts from 79 users focused on treatment decision discussions. Posts were manually reviewed, and relevant text segments were coded and grouped into categories and overall themes. Results: Eighty-six percent (73/85) of users in the overall QDA had relevant information about the key objectives. The most commonly discussed treatment experience theme was the humanistic burden of AML or MDS in terms of emotional/physical impact and impact on family (86{\%}, 63/73 of users), followed by treatment decisions (56{\%}, 41/73) and unmet needs (50{\%}, 37/73). In the QDA of treatment decisions, 60 posts from 45 users contained relevant information. Patients commonly reported the desire to reach specific milestones, including birthdays and weddings. They wished for a better quality of life over quantity of life, did not want the risk of suffering from side effects, and expressed a clear preference to be at home rather than in a hospital or care home. Conclusions: This study was a novel application of disease-specific social media. It highlighted experiences in the current treatment of AML and MDS, including information gaps, patient/caregiver uncertainty, and the importance of understanding patients'/caregivers' goals and opinions. A clear finding from this research was the importance of reaching certain personal life goals and being at home with family and friends. The analysis showed that patients/caregivers face additional challenges, including humanistic impacts and a lack of information regarding treatment options. ", issn="1438-8871", doi="10.2196/14285", url="//www.mybigtv.com/2019/11/e14285/", url="https://doi.org/10.2196/14285", url="http://www.ncbi.nlm.nih.gov/pubmed/31755871" }